Biosimilars-why terminology matters

被引：155

作者：

Weise, Martina ^{[1
]}

Bielsky, Marie-Christine ^{[2
]}

De Smet, Karen ^{[3
]}

Ehmann, Falk ^{[4
]}

Ekman, Niklas ^{[5
]}

Narayanan, Gopalan ^{[2
]}

Heim, Hans-Karl ^{[1
]}

Heinonen, Esa ^{[5
]}

Ho, Kowid ^{[6
]}

Thorpe, Robin ^{[7
]}

Vleminckx, Camille ^{[4
]}

Wadhwa, Meenu ^{[7
]}

Schneider, Christian K. ^{[8
,9
]}

机构：

[1] Bundesinst Arzneimittel & Med Prod BfArM, Bonn, Germany

[2] Med & Healthcare Prod Regulatory Agcy MHRA, London, England

[3] Fed Agcy Med & Hlth Prod FAGG, Brussels, Belgium

[4] EMA, London, England

[5] Finnish Med Agcy FIMEA, Helsinki, Finland

[6] Agence Francaise Securite Sanit Prod Sante Afssap, Paris, France

[7] NIBSC, Hertford, England

[8] Paul Ehrlich Inst, D-6070 Langen, Germany

[9] Twincore Ctr Expt & Clin Infect Res, Hannover, Germany

来源：

NATURE BIOTECHNOLOGY | 2011年 / 29卷 / 08期

关键词：

COMPARABILITY;

D O I：

10.1038/nbt.1936

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：690 / 693

页数：4

共 17 条

[1]

[Anonymous], 2009, Guidelines on evaluation of similar biotherapeutic products (SBPs)

[2]

[Anonymous], 2003, AIDS ALERT, V18, P79

[3]

Brockmeyer C, 2009, EJHP PRACT, V15, P34

[4] Characterizing biological products and assessing comparability following manufacturing changes [J].

Chirino, AJ ;

Mire-Sluis, A .

NATURE BIOTECHNOLOGY, 2004, 22 (11) :1383-1391

[5] Biosimilar epoetins: An analysis based on recently implemented European medicines - Evaluation Agency guidelines on comparability of biopharmaceutical proteins [J].

Combe, C ;

Tredree, RL ;

Schellekens, H .

PHARMACOTHERAPY, 2005, 25 (07) :954-962

[6]

Committee for Medicinal Products for Human Use, BIOS GUID

[7]

European Medicines Agency, 2007, GUID COMP BIOT DER M

[8]

European Medicines Agency, EPARS AUTH MED PROD

[9]

Federal Drug Administration, FOLL ON PROT PROD RE

[10] Impact of Illegal Trade on the Quality of Epoetin Alfa in Thailand [J].

Fotiou, Fotis ;

Aravind, Suresh ;

Wang, Ping-Ping ;

Nerapusee, Osot .

CLINICAL THERAPEUTICS, 2009, 31 (02) :336-346

← 1 2 →